the pharmacokinetics of 9-beta-d-arabinofuranosyl-2-fluoroadenine ( f-ara-a ) in plasma and its biologically active 5'-triphosphate ( f-ara-atp ) in leukemic cells obtained from the peripheral blood and bone marrow was evaluated in patients with hematologic malignancies subsequent to the first dose of 20-125 mg/m2 per day for 5 days of f-ara-a 5'-monophosphate ( f-ara-amp ) administered as an iv bolus over 30 min .
C0032105
plasma
C0229664
peripheral blood